Hello again, I'm stage for nodular scalp melanoma with pelvic mets. Braf positive. History of heart attack 2020. Offered these 2 treatment options. Difficult decision, wondering if anyone else had similar decision to make. Any advice. I've read cardiac specific AE slightly higher with niv/retalumab but far less likelihood of grade 3 & 4 adverse effects. 23 percent compared with upwards of 60 percent ipi/Niv. But that ipi/Niv for Braf mutant, to treat aggressive disease. Oncology registrar I saw for consent not really guiding either way
